Source:http://linkedlifedata.com/resource/pubmed/id/19357398
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
22
|
pubmed:dateCreated |
2009-5-29
|
pubmed:abstractText |
Matriptase-2 is a transmembrane serine protease that negatively regulates hepcidin expression by cleaving membrane-bound hemojuvelin. Matriptase-2 has a complex ectodomain, including a C-terminal serine protease domain and its activation requires an autocatalytic cleavage. Matriptase-2 mutations have been reported in several patients with iron-refractory iron deficiency anemia. Here we describe a patient with 2 missense mutations in the second class A low-density lipoprotein receptor (LDLRA) domain. Functional studies of these 2 mutations and of a previously reported mutation in the second C1r/C1s, urchin embryonic growth factor and bone morphogenetic protein 1 (CUB) domain were performed. Transfection of mutant cDNAs showed that membrane targeting of the 2 LDLRA mutants was impaired, with Golgi retention of the variants. The activating cleavage was absent for the LDLRA mutants and reduced for the CUB mutant. All 3 mutated proteins were still able to physically interact with hemojuvelin but only partially repressed hepcidin expression compared with wild-type matriptase-2. Our results underline the importance of LDLRA and CUB domains of matriptase-2.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antimicrobial Cationic Peptides,
http://linkedlifedata.com/resource/pubmed/chemical/Iron,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Serine Endopeptidases,
http://linkedlifedata.com/resource/pubmed/chemical/TMPRSS6 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/hepcidin
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1528-0020
|
pubmed:author |
pubmed-author:BeaumontCaroleC,
pubmed-author:CamaschellaClaraC,
pubmed-author:GrandchampBernardB,
pubmed-author:GuillemFlaviaF,
pubmed-author:KannengiesserCarolineC,
pubmed-author:NaiAntonellaA,
pubmed-author:OudinClaireC,
pubmed-author:PaganiAlessiaA,
pubmed-author:SilvaMurielM,
pubmed-author:SilvestriLauraL,
pubmed-author:ToutainFabienneF
|
pubmed:issnType |
Electronic
|
pubmed:day |
28
|
pubmed:volume |
113
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5605-8
|
pubmed:meshHeading |
pubmed-meshheading:19357398-Anemia, Iron-Deficiency,
pubmed-meshheading:19357398-Antimicrobial Cationic Peptides,
pubmed-meshheading:19357398-Child,
pubmed-meshheading:19357398-HeLa Cells,
pubmed-meshheading:19357398-Humans,
pubmed-meshheading:19357398-Iron,
pubmed-meshheading:19357398-Male,
pubmed-meshheading:19357398-Membrane Proteins,
pubmed-meshheading:19357398-Models, Biological,
pubmed-meshheading:19357398-Mutation,
pubmed-meshheading:19357398-Serine Endopeptidases,
pubmed-meshheading:19357398-Signal Transduction,
pubmed-meshheading:19357398-Treatment Failure
|
pubmed:year |
2009
|
pubmed:articleTitle |
Molecular mechanisms of the defective hepcidin inhibition in TMPRSS6 mutations associated with iron-refractory iron deficiency anemia.
|
pubmed:affiliation |
Vita-Salute University, San Raffaele Scientific Institute, Milan, Italy.
|
pubmed:publicationType |
Journal Article,
Case Reports,
Research Support, Non-U.S. Gov't
|